• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  rilonacept
Date Designated:  01/09/2013
Orphan Designation:  Treatment of familial Mediterranean fever
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Philip J Hashkes, MD, MSc.
Head, Section of Pediatric Rheumatology
9500 Euclid Avenue
Cleveland, Ohio 044195
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.